Analysis of Acute Exposure to Environmental Pollutants and Severity of Covid-19: Case Study in Mexico City

Main Article Content

Carla Paola Sánchez Ríos
Luis Sauchay Romero
Norma Angélica Téllez Navarrete

Abstract

Introduction: exposure to PM2.5 and PM10 particles has been associated with severity in COVID-19. Our objective was to identify the association of the severity of the COVID-19 disease with acute exposure to contamination according to the place of residence.
Methods: retrospective cross-sectional study of 89 COVID-19 patients at the "Ismael Cosío Villegas" National Institute of Respiratory Diseases, during March-May 2020. Concentrations of environmental pollutants (PM2.5, PM10, NO2 and O3) were evaluated. A logistic regression model was implemented for the probability of the effect of acute exposure on COVID-19 severity and acute exposure.
Results: the exposure to PM2,5 and O3 of seriously ill patients was higher compared to the mild ones. Exposure to O3 > 0.05 ppm and O3 < 0.05 ppm was associated with lung disease (p <0.05). PM2.5 concentrations increase the probability of aggravation (p 0.04).
Conclusion: the evidence suggests a relationship between exposure to PM2.5 and severity of COVID-19. 
Keywords: COVID-19, pollution, severity, pneumonia.

Downloads

Download data is not yet available.

Article Details

How to Cite
Sánchez Ríos, C. P. ., Sauchay Romero, L. ., & Téllez Navarrete, N. A. . (2022). Analysis of Acute Exposure to Environmental Pollutants and Severity of Covid-19: Case Study in Mexico City. Respirar, 13(4), 175–186. Retrieved from https://respirar.alatorax.org/index.php/respirar/article/view/91
Section
Artículos Originales
Author Biographies

Carla Paola Sánchez Ríos

Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas” Ciudad de México.
Autor corresponsal: pao1144tost@gmail.com

Luis Sauchay Romero

Estudiante de Doctorado del Programa de Salud pública y medio ambiente. Fundación Oswaldo Cruz (ENSP - FIOCRUZ / CAPES). Rio de Janeiro, Brasil.

Norma Angélica Téllez Navarrete

Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas” Ciudad de México.